Soluble ST2 Plasma Concentrations Predict Mortality in HBV-Related Acute-on-Chronic Liver FailureReportar como inadecuado

Soluble ST2 Plasma Concentrations Predict Mortality in HBV-Related Acute-on-Chronic Liver Failure - Descarga este documento en PDF. Documentación en PDF para descargar gratis. Disponible también para leer online.

Mediators of Inflammation - Volume 2015 2015, Article ID 535938, 10 pages -

Research Article

Department of Infectious Disease, The Third Affiliated Hospital of Sun-Yet-Sen University, Guangzhou, Guangdong 510630, China

Key Laboratory of Tropical Disease Control, Sun Yat-Sen University, Ministry of Education, Guangzhou, Guangdong 510080, China

Received 19 September 2014; Accepted 31 December 2014

Academic Editor: Edda Sciutto-Conde

Copyright © 2015 Ziying Lei et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Hepatitis B virus-related acute-on-chronic liver failure HBV-ACLF is a rapidly progressing and frequently fatal condition. The aim of this study was to determine whether interleukin- IL- 33 and soluble ST2 sST2 were associated with disease severity and mortality in HBV-ACLF. We found that plasma levels of sST2 but not IL-33 were higher in HBV-ACLF patients compared with chronic hepatitis B CHB patients and healthy controls. However, plasma levels of IL-33, TNF-α, IFN-γ, and IL-10 did not correlate with sST2 levels. Similarly, immunohistochemistry revealed low IL-33 expression and high ST2 expression in liver sections of patients with HBV-ACLF. Evaluation of dynamic changes of sST2 in HBV-ACLF showed that plasma sST2 levels increased over time in patients who died during the 180-day follow-up but decreased in those who survived. In addition, plasma sST2 level after week 1 correlated with disease severity, as assessed by total bilirubin, prothrombin time, and model for end-stage liver disease score. Results of Kaplan-Meier survival analysis showed that higher sST2 concentration 87 ng-mL at week 3 was associated with poor survival. These findings indicate the potential usefulness of sST2 as a predictor of disease severity and in making treatment decisions for patients with HBV-ACLF.

Autor: Ziying Lei, Zhishuo Mo, Jianyun Zhu, Xiuqing Pang, Xingrong Zheng, Zhebin Wu, Ke Wang, Xinhua Li, Dongying Xie, and Zhili



Documentos relacionados